Consequently, institutional capital is flowing into Canadian cannabis businesses. Last year liquor company Constellation Brands ( STZ ) invested more than $200 million in a cannabis company, and another company set its self up for the $1 billion acquisition of CanniMed Therapeutics Inc. that was funded partially by a large PIPE transaction.